ConforMIS Inc (CFMS) Misses Q3 EPS by 7c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- Wall St subdued as markets pause after S&P record high; data, Mideast in focus
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
ConforMIS Reports Third Quarter 2015 Financial Results
November 2, 2015 4:05 PM ESTBEDFORD, Mass., Nov. 2, 2015 (GLOBE NEWSWIRE) -- ConforMIS, Inc. (NASDAQ: CFMS), a medical technology company that uses its proprietary iFit Image-to-Implant technology platform to develop, manufacture and sell joint replacement implants that are customized to fit each patient's unique anatomy, announced today financial results for the third quarter ended September 30, 2015.
Q3 Summary:
ConforMIS resumed full production in October after resolving the issues associated with the voluntary recall that it announced on August 31, 2015 Total revenue of $13.9 million, up 16% year-over-year on a reported basis and up 20% year-over-year on a constant currency... MoreConforMIS Reports Third Quarter 2015 Financial Results
November 2, 2015 4:05 PM ESTBEDFORD, Mass., Nov. 2, 2015 (GLOBE NEWSWIRE) -- ConforMIS, Inc. (NASDAQ: CFMS), a medical technology company that uses its proprietary iFit Image-to-Implant technology platform to develop, manufacture and sell joint replacement implants that are customized to fit each patient's unique anatomy, announced today financial results for the third quarter ended September 30, 2015.
Q3 Summary:
ConforMIS resumed full production in October after resolving the issues associated with the voluntary recall that it announced on August 31, 2015 Total revenue of $13.9 million, up 16% year-over-year on a reported basis and up 20% year-over-year on a constant currency... More